JFL Life

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0LA901015
  • NSEID: JFLLIFE
  • BSEID:
INR
10.95
0.5 (4.78%)
BSENSE

Jul 07, 03:31 PM

BSE+NSE Vol: 66000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 76.25% vs 8.68% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 80.40% vs 15.73% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 30.88% vs -42.01% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 25.72% vs 17.74% in Mar 2024

Compare Profit and Loss Results of JFL Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
82.00
142.00
-60.00
-42.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
82.00
142.00
-60.00
-42.25%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
66.00
108.00
-42.00
-38.89%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
6.00
-5.00
-83.33%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
4.00
0.00
4.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
23.00
-23.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
73.00
136.00
-63.00
-46.32%
Operating Profit (PBDIT) excl Other Income
8.00
6.00
2.00
33.33%
Other Income
0.00
5.00
-5.00
-100.00%
Operating Profit (PBDIT)
8.00
11.00
-3.00
-27.27%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
7.00
8.00
-1.00
-12.50%
Depreciation
0.00
12.00
-12.00
-100.00%
Profit Before Taxation & Exceptional Items
6.00
-3.00
9.00
300.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-19.00
25.00
131.58%
Provision for Tax
1.00
-4.00
5.00
125.00%
Profit After Tax
4.00
-14.00
18.00
128.57%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
8.00
-46.00
54.00
117.39%
Profit Available for appropriations
13.00
-61.00
74.00
121.31%
Appropriations
13.00
-61.00
74.00
121.31%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.26
-2.95
4.21
142.71%
Profit And Loss - Net Sales
Net Sales 82.04 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 76.25% vs 8.68% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 80.40% vs 15.73% in Mar 2024

Profit And Loss - Interest
Interest 1.08 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.88% vs -42.01% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 4.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.72% vs 17.74% in Mar 2024